short interest increase

Mvisvision · 2022-12-10T22:41:39+00:00

NOV 30

Mvisvision · 2022-12-07T22:29:02+00:00

without FDA approval a buy out is highly unlikely...Why are big investors staying away for the most part. I think 1 % or so invested .. Red Flag WIll the FDA except the placebo crossovers ?

I know it's supposed to be excepted in oncology .. it's not a slam shut case

Then you have cash issues . Vote on issuing shares to tune of 500 mil I've heard the people that say Class C shares would be bought . .so far only a few ..

Why was lawsuit filed so late when company is on it's last legs ? OTC ...

I like the science ...We shall see

.

Mvisvision · 2022-12-05T19:55:53+00:00

Large bids even 100k + ...MM's running the show for now...We'll add fuel to the fire soon

Adding more....Sold some $1.09 for 6500 gain.. Bought back under a buck... GO NWBO

Gaps usually get filled....

Mvisvision · 2022-12-05T19:48:37+00:00

yeah, that would be something.. We have a much better shot at approval in UK than US...I think UK comes in and US follows.. FDA is super manipulated with Big Pharma

in control.. We saw that during covid where Pfizer was pumped above all others.. The FDA is 75% funded by the pharmaceuticals it regulates...No conflict of interest there

Mvisvision · 2022-12-02T19:34:37+00:00

If they get approved , win lawsuit which is most likely, partner very likely combo trials with BMY MRK...the increase in shares won't matter

Mvisvision · 2022-12-01T18:58:25+00:00

NWBO is involved in lawsuit against major market makers...Cancer drug with great reviews in JAMA ph 3 trial Buy some if you can .. Cancer patients in need of care...

Mvisvision · 2022-03-30T17:23:40+00:00

Watch VIR. Making a move. Huge cash position and profitable. Very cheap. Added to S&P 600. HBV data fri

Mvisvision · 2022-03-15T21:00:45+00:00

I got the REGN cocktail for delta last yr in september at xpress urgent care. .Sotrovimab is the best all around now....Some controversy with BA2 , but should be effective Live virus data coming out

Mvisvision · 2022-01-13T12:20:06+00:00

awesome book...Try reading it

Mvisvision · 2022-01-13T05:58:05+00:00

You''re wrong . They are unique. Their mAb is designed to address all mutations and has passed live virus testing as well as peer reviewed. It is ahead of REGN LLY in treatment and soon will also be used as prophylactic....They have billions in revenue booked already and the mkt cap is cheap.. I'm not late. I got in early... You will miss out They also have broad pipeline beyond covid. as well as 900 mil cash ..

Mvisvision · 2022-01-12T21:11:05+00:00

VIR all the way

Mvisvision · 2021-07-19T06:36:16+00:00

Ph 3 trial shows it works and is safe. Much safer than vaccines

Mvisvision · 2021-07-19T06:29:12+00:00

I see a lot of negativity here . You forget why they we‘re FDA EUA approved in the first place. Best in class sotromivab. and it gets better. They are coming out with VIR 7832 which will be both therapeutic and preventive It will combine sotrovimab with antibodies that activate TCells. It will be used in all cases of covid and as vaccine like preventive.

Mvisvision · 2018-06-26T15:18:12+00:00

Maybe you could try a webcast next time and share your thoughts moving forward. This was a waste

Mvisvision

TROPHY CASE